Boston Scientific (NYSE:BSX) Director Ernest Mario unloaded 10,000 shares of the stock in a transaction that occurred on Wednesday, October 8th. The stock was sold at an average price of $12.06, for a total transaction of $120,600.00. Following the transaction, the director now directly owns 267,855 shares of the company’s stock, valued at approximately $3,230,331. Boston Scientific Corporation (NYSE:BSX) in last trading activity advanced 0.09% to close at $11.45. Company weekly performance is -3.94% while its quarterly performance stands at -9.63%. Boston Scientific Corporation (NYSE:BSX) is -18.68% away from its 52 week high.Mondelez International Inc. (NASDAQ:MDLZ) has named Brian Gladden, 49, executive vice-president and chief financial officer, effective Dec. 1. Most recently, Gladden was senior vice-president and chief financial officer of Dell Inc. He was previously president and chief executive of SABIC Innovative Plastics, the successor to General Electric Co.'s Plastics business, after spending almost 20 years in senior financial and operational positions at GE. On last trading day Mondelez International, Inc. (NASDAQ:MDLZ) fell -1.74% to close at $32.10. Its volatility for the week is 2.08% while volatility for the month is 1.84%. MDLZ's sales growth for past 5 years was -2.70% and its EPS growth for past 5 years was 3.20%. Mondelez International, Inc. (NASDAQ:MDLZ) monthly performance is -8.99%.Vishay Precision Group, Inc. (NYSE:VPG), a leading producer of precision sensors and systems, based on its resistive foil technology, will release results for its Fiscal 2014 third quarter results at approximately 8:00 a.m. EST (7:00 a.m. CST) on November 5, 2014. On last trading day Vishay Precision Group, Inc. (NYSE:VPG) advanced 4.18% to close at $16.95. Its volatility for the week is 4.27% while volatility for the month is 2.99%. VPG's sales growth for past 5 years was -0.10% and its EPS growth for past 5 years was 15.50%. Vishay Precision Group, Inc. (NYSE:VPG) monthly performance is 12.77%.Enzymotec Ltd. (NASDAQ:ENZY) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.02 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.10 by $0.08. The company had revenue of $11.50 million for the quarter, compared to the consensus estimate of $14.88 million. Enzymotec’s revenue was down 40.3% compared to the same quarter last year. Analysts expect that Enzymotec will post $0.36 EPS for the current fiscal year. Enzymotec Ltd. (NASDAQ:ENZY) has its institutional ownership stands at 57.40%. In last trading activity company's stock closed at $6.51.BioFuel Energy Corp. (NASDAQ:BIOF) on Sept. 23 made an announcement relating to the Company’s previously announced rights offering. Trading of the subscription rights on The Nasdaq Capital Market under the symbol “BIOFR” first occurred on Sept. 23, 2014, and as a result NASDAQ has informed the Company that the ex-dividend date will be tomorrow, Sept. 24, 2014. The subscription rights will expire and have no value if they are not exercised by 5:00 p.m., New York City time, on October 17, 2014. On Thursday shares of BioFuel Energy Corp. (NASDAQ:BIOF) closed at $5.58. Company's EPS growth for next 5 years is recorded as 20.00%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
